Cargando…
Heterozygous expression of the Alzheimer’s disease-protective PLCγ2 P522R variant enhances Aβ clearance while preserving synapses
BACKGROUND: A rare coding variant, P522R, in the phospholipase C gamma 2 (PLCG2) gene has been identified as protective against late-onset Alzheimer’s disease (AD), but the mechanism is unknown. PLCG2 is exclusively expressed in microglia within the central nervous system, and altered microglial fun...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329165/ https://www.ncbi.nlm.nih.gov/pubmed/35895133 http://dx.doi.org/10.1007/s00018-022-04473-1 |
_version_ | 1784757879246422016 |
---|---|
author | Solomon, Shiden Sampathkumar, Nirmal Kumar Carre, Ivo Mondal, Mrityunjoy Chennell, George Vernon, Anthony C. Ruepp, Marc-David Mitchell, Jacqueline C |
author_facet | Solomon, Shiden Sampathkumar, Nirmal Kumar Carre, Ivo Mondal, Mrityunjoy Chennell, George Vernon, Anthony C. Ruepp, Marc-David Mitchell, Jacqueline C |
author_sort | Solomon, Shiden |
collection | PubMed |
description | BACKGROUND: A rare coding variant, P522R, in the phospholipase C gamma 2 (PLCG2) gene has been identified as protective against late-onset Alzheimer’s disease (AD), but the mechanism is unknown. PLCG2 is exclusively expressed in microglia within the central nervous system, and altered microglial function has been implicated in the progression of AD. METHODS: Healthy control hiPSCs were CRISPR edited to generate cells heterozygous and homozygous for the PLCG2(P522R) variant. Microglia derived from these hiPSC’s were used to investigate the impact of PLCγ2(P522R) on disease relevant processes, specifically microglial capacity to take up amyloid beta (Aβ) and synapses. Targeted qPCR assessment was conducted to explore expression changes in core AD linked and microglial genes, and mitochondrial function was assessed using an Agilent Seahorse assay. RESULTS: Heterozygous expression of the P522R variant resulted in increased microglial clearance of Aβ, while preserving synapses. This was associated with the upregulation of a number of genes, including the anti-inflammatory cytokine Il-10, and the synapse-linked CX3CR1, as well as alterations in mitochondrial function, and increased cellular motility. The protective capacity of PLCγ2(P522R) appeared crucially dependent on (gene) ‘dose’, as cells homozygous for the variant showed reduced synapse preservation, and a differential gene expression profile relative to heterozygous cells. CONCLUSION: These findings suggest that PLCγ2(P522R) may result in increased surveillance by microglia, and prime them towards an anti-inflammatory state, with an increased capacity to respond to increasing energy demands, but highlights the delicate balance of this system, with increasing PLCγ2(P522R) ‘dose’ resulting in reduced beneficial impacts. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-022-04473-1. |
format | Online Article Text |
id | pubmed-9329165 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-93291652022-07-29 Heterozygous expression of the Alzheimer’s disease-protective PLCγ2 P522R variant enhances Aβ clearance while preserving synapses Solomon, Shiden Sampathkumar, Nirmal Kumar Carre, Ivo Mondal, Mrityunjoy Chennell, George Vernon, Anthony C. Ruepp, Marc-David Mitchell, Jacqueline C Cell Mol Life Sci Original Article BACKGROUND: A rare coding variant, P522R, in the phospholipase C gamma 2 (PLCG2) gene has been identified as protective against late-onset Alzheimer’s disease (AD), but the mechanism is unknown. PLCG2 is exclusively expressed in microglia within the central nervous system, and altered microglial function has been implicated in the progression of AD. METHODS: Healthy control hiPSCs were CRISPR edited to generate cells heterozygous and homozygous for the PLCG2(P522R) variant. Microglia derived from these hiPSC’s were used to investigate the impact of PLCγ2(P522R) on disease relevant processes, specifically microglial capacity to take up amyloid beta (Aβ) and synapses. Targeted qPCR assessment was conducted to explore expression changes in core AD linked and microglial genes, and mitochondrial function was assessed using an Agilent Seahorse assay. RESULTS: Heterozygous expression of the P522R variant resulted in increased microglial clearance of Aβ, while preserving synapses. This was associated with the upregulation of a number of genes, including the anti-inflammatory cytokine Il-10, and the synapse-linked CX3CR1, as well as alterations in mitochondrial function, and increased cellular motility. The protective capacity of PLCγ2(P522R) appeared crucially dependent on (gene) ‘dose’, as cells homozygous for the variant showed reduced synapse preservation, and a differential gene expression profile relative to heterozygous cells. CONCLUSION: These findings suggest that PLCγ2(P522R) may result in increased surveillance by microglia, and prime them towards an anti-inflammatory state, with an increased capacity to respond to increasing energy demands, but highlights the delicate balance of this system, with increasing PLCγ2(P522R) ‘dose’ resulting in reduced beneficial impacts. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-022-04473-1. Springer International Publishing 2022-07-27 2022 /pmc/articles/PMC9329165/ /pubmed/35895133 http://dx.doi.org/10.1007/s00018-022-04473-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Solomon, Shiden Sampathkumar, Nirmal Kumar Carre, Ivo Mondal, Mrityunjoy Chennell, George Vernon, Anthony C. Ruepp, Marc-David Mitchell, Jacqueline C Heterozygous expression of the Alzheimer’s disease-protective PLCγ2 P522R variant enhances Aβ clearance while preserving synapses |
title | Heterozygous expression of the Alzheimer’s disease-protective PLCγ2 P522R variant enhances Aβ clearance while preserving synapses |
title_full | Heterozygous expression of the Alzheimer’s disease-protective PLCγ2 P522R variant enhances Aβ clearance while preserving synapses |
title_fullStr | Heterozygous expression of the Alzheimer’s disease-protective PLCγ2 P522R variant enhances Aβ clearance while preserving synapses |
title_full_unstemmed | Heterozygous expression of the Alzheimer’s disease-protective PLCγ2 P522R variant enhances Aβ clearance while preserving synapses |
title_short | Heterozygous expression of the Alzheimer’s disease-protective PLCγ2 P522R variant enhances Aβ clearance while preserving synapses |
title_sort | heterozygous expression of the alzheimer’s disease-protective plcγ2 p522r variant enhances aβ clearance while preserving synapses |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329165/ https://www.ncbi.nlm.nih.gov/pubmed/35895133 http://dx.doi.org/10.1007/s00018-022-04473-1 |
work_keys_str_mv | AT solomonshiden heterozygousexpressionofthealzheimersdiseaseprotectiveplcg2p522rvariantenhancesabclearancewhilepreservingsynapses AT sampathkumarnirmalkumar heterozygousexpressionofthealzheimersdiseaseprotectiveplcg2p522rvariantenhancesabclearancewhilepreservingsynapses AT carreivo heterozygousexpressionofthealzheimersdiseaseprotectiveplcg2p522rvariantenhancesabclearancewhilepreservingsynapses AT mondalmrityunjoy heterozygousexpressionofthealzheimersdiseaseprotectiveplcg2p522rvariantenhancesabclearancewhilepreservingsynapses AT chennellgeorge heterozygousexpressionofthealzheimersdiseaseprotectiveplcg2p522rvariantenhancesabclearancewhilepreservingsynapses AT vernonanthonyc heterozygousexpressionofthealzheimersdiseaseprotectiveplcg2p522rvariantenhancesabclearancewhilepreservingsynapses AT rueppmarcdavid heterozygousexpressionofthealzheimersdiseaseprotectiveplcg2p522rvariantenhancesabclearancewhilepreservingsynapses AT mitchelljacquelinec heterozygousexpressionofthealzheimersdiseaseprotectiveplcg2p522rvariantenhancesabclearancewhilepreservingsynapses |